- 12-Week # shares bought: 5,478
- 12-Week # shares sold: 15,592
- 24-Week # shares bought: 5,478
- 24-Week # shares sold: 15,592
McCaskill requested that four more drug companies and three drug distributors turn over documents.
IntelliPharmaceuticals has a bio-equivalent to OxyContin, but says it is harder to tamper with. The pharma company is hoping to gain a recommendation from an FDA committee on Wednesday.